148 related articles for article (PubMed ID: 8653319)
21. The purification and development of a radioimmunoassay for beta-core fragment of human chorionic gonadotrophin in urine: application as a marker of gynaecological cancer in premenopausal and postmenopausal women.
Lee CL; Iles RK; Shepherd JH; Hudson CN; Chard T
J Endocrinol; 1991 Sep; 130(3):481-9. PubMed ID: 1719119
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of human chorionic gonadotropin beta genes 3, 5 and 8 in tumor tissue and urinary cells of bladder cancer patients.
Hotakainen K; Lintula S; Jarvinen R; Paju A; Stenman J; Rintala E; Stenman UH
Tumour Biol; 2007; 28(1):52-6. PubMed ID: 17139196
[TBL] [Abstract][Full Text] [Related]
23. Urinary beta-HCG in benign and malignant urinary tract diseases.
Halim AB; Barakat M; el-Zayat AM; Daw M; el-Ahmady O
Dis Markers; 1995 Mar; 12(2):109-15. PubMed ID: 7542189
[TBL] [Abstract][Full Text] [Related]
24. Urinary human chorionic gonadotropin free beta-subunit and beta-core fragment: a new marker of gynecological cancers.
Cole LA; Wang YX; Elliott M; Latif M; Chambers JT; Chambers SK; Schwartz PE
Cancer Res; 1988 Mar; 48(5):1356-60. PubMed ID: 3342414
[TBL] [Abstract][Full Text] [Related]
25. Urinary EpCAM in urothelial bladder cancer patients: characterisation and evaluation of biomarker potential.
Bryan RT; Shimwell NJ; Wei W; Devall AJ; Pirrie SJ; James ND; Zeegers MP; Cheng KK; Martin A; Ward DG
Br J Cancer; 2014 Feb; 110(3):679-85. PubMed ID: 24292452
[TBL] [Abstract][Full Text] [Related]
26. Urinary vascular endothelial growth factor and its correlation with bladder cancer recurrence rates.
Crew JP; O'Brien T; Bicknell R; Fuggle S; Cranston D; Harris AL
J Urol; 1999 Mar; 161(3):799-804. PubMed ID: 10022687
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of urinary cytology and other biomarkers for recurrence and progression in bladder cancer: a prospective study.
Bell MD; Yafi FA; Brimo F; Steinberg J; Aprikian AG; Tanguay S; Kassouf W
World J Urol; 2016 Oct; 34(10):1405-9. PubMed ID: 26906030
[TBL] [Abstract][Full Text] [Related]
28. Urinary screening tests for fetal Down syndrome: II. Hyperglycosylated hCG.
Cole LA; Shahabi S; Oz UA; Rinne KM; Omrani A; Bahado-Singh RO; Mahoney MJ
Prenat Diagn; 1999 Apr; 19(4):351-9. PubMed ID: 10327141
[TBL] [Abstract][Full Text] [Related]
29. Serum and urinary levels of beta human chorionic gonadotrophin in patients with transitional cell carcinoma.
McLoughlin J; Pepera T; Bridger J; Williams G
Br J Cancer; 1991 May; 63(5):822-4. PubMed ID: 1710137
[TBL] [Abstract][Full Text] [Related]
30. Combination assay of urinary beta-core fragment of human chorionic gonadotropin with serum tumor markers in gynecologic cancers.
Kinugasa M; Nishimura R; Koizumi T; Morisue K; Higashida T; Natazuka T; Nakagawa T; Isobe T; Baba S; Hasegawa K
Jpn J Cancer Res; 1995 Aug; 86(8):783-9. PubMed ID: 7559103
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance of urinary vascular endothelial growth factor in patients with superficial bladder tumors.
Jeon SH; Lee SJ; Chang SG
Oncol Rep; 2001; 8(6):1265-7. PubMed ID: 11605046
[TBL] [Abstract][Full Text] [Related]
32. Problems in the use of urinary hCG-beta-core as a tumor marker in gynecologic cancer.
Ngan HY; Yeung WS; Cheng GT; Wong LC; de Madeiros SF; Norman RJ; Ma HK
Int J Gynecol Cancer; 1995 Jan; 5(1):15-19. PubMed ID: 11578447
[TBL] [Abstract][Full Text] [Related]
33. [Expression and clinical significance of nuclear matrix protein 22 and cytokeratin 18 in transitional cell carcinoma of the bladder].
Song JW; DU LL; Zhao XW; Jing JX; Han CZ; Cui Y; Liu JW; Hao HL; Wang ZG; Mi ZG
Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):274-7. PubMed ID: 19615282
[TBL] [Abstract][Full Text] [Related]
34. Expression and secretion of the beta subunit of human chorionic gonadotropin by bladder carcinoma in vivo and in vitro.
Nishimura R; Koizumi T; Morisue K; Yamanaka N; Lalwani R; Yoshimura M; Nakagawa T; Shii K; Hasegawa K; Baba S
Cancer Res; 1995 Apr; 55(7):1479-84. PubMed ID: 7882356
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic value of neutrophil gelatinase-associated lipocalin/matrix metalloproteinase-9 pathway in transitional cell carcinoma of the bladder.
Candido S; Di Maso M; Serraino D; McCubrey JA; Bortolus R; Zanin M; Battiston M; Salemi R; Libra M; Polesel J
Tumour Biol; 2016 Jul; 37(7):9855-63. PubMed ID: 26810191
[TBL] [Abstract][Full Text] [Related]
36. Assessment of serial CEA determinations in urine of patients with bladder carcinoma.
Zimmerman R; Wahren B; Edsmyr F
Cancer; 1980 Oct; 46(8):1802-9. PubMed ID: 7427883
[TBL] [Abstract][Full Text] [Related]
37. Low-dose Human Chorionic Gonadotropin Stimulation Test as a Prognostic Incontinent Indicator in Boys With Bladder Exstrophy-epispadias Complex.
Sabetkish N; Eftekharzadeh S; Elmi A; Talab SS; Kajbafzadeh AM
Urology; 2017 Mar; 101():133-138. PubMed ID: 28039050
[TBL] [Abstract][Full Text] [Related]
38. Measurement of urinary free beta-human chorionic gonadotropin by immunoradiometric assay.
Seki K; Mitsui C; Nagata I
Gynecol Obstet Invest; 1995; 40(3):162-7. PubMed ID: 8529948
[TBL] [Abstract][Full Text] [Related]
39. Expression of human chorionic gonadotropin beta subunit genes in superficial and invasive bladder carcinomas.
Lazar V; Diez SG; Laurent A; Giovangrandi Y; Radvanyi F; Chopin D; Bidart JM; Bellet D; Vidaud M
Cancer Res; 1995 Sep; 55(17):3735-8. PubMed ID: 7543817
[TBL] [Abstract][Full Text] [Related]
40. The effects of beta-human chorionic gonadotrophin on the in vitro growth of bladder cancer cell lines.
Gillott DJ; Iles RK; Chard T
Br J Cancer; 1996 Feb; 73(3):323-6. PubMed ID: 8562337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
